23 February 2026
Management Discussion and Analysis Yearly Ending 31 Dec 2025 (Revised)
20 February 2026
Management Discussion and Analysis Yearly Ending 31 Dec 2025
20 February 2026
The Board of Directors Meeting 1/2569 to consider the approval of the annual dividend and Schedule of Annual General Meeting of Shareholders 2026 (Revised)
20 February 2026
Financial Performance Yearly (F45) (Audited)
20 February 2026
Schedule of Annual General Meeting of Shareholders
20 February 2026
Financial Statement Yearly 2025 (Audited)
27 January 2026
Report the use of the capital increase fund received from the offer to sell the additional common shares to the public for the first time (IPO) as of 31 December 2025.